Stocks · Korea
001060
KOSPI
JW Pharmaceutical
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-07 basis
PER10.91x
PBR1.81x
EPS2,534 KRW
BPS15,290 KRW
ROE18.73%
Dividend yield2.35%
DPS650 KRW
Payout ratio25.65%
Returns and 52-week range
1W+4.73%
1M+1.84%
3M+6.96%
6M-11.52%
1Y+23.71%
YTD+7.17%
52W high39,250원
52W low20,700원
From 52W high-29.55%
Financial results (consolidated)
| Period | Revenue | Operating income | Net income | OP margin |
|---|---|---|---|---|
| 2022 | 6,844억 | 630억 | 299억 | 9.2% |
| 2023 | 7,485억 | 1,003억 | 384억 | 13.4% |
| 2024 | 7,194억 | 825억 | 650억 | 11.5% |
| 2025 | 7,753억 | 945억 | 615억 | 12.2% |
| Quarterly | ||||
| 2024 4Q | 1,879억 | 181억 | 166억 | 9.6% |
| 2025 1Q | 1,852억 | 220억 | 175억 | 11.9% |
| 2025 2Q | 1,911억 | 250억 | -19억 | 13.1% |
| 2025 3Q | 2,000억 | 320억 | 306억 | 16.0% |
| 2025 4Q | 1,989억 | 155억 | 153억 | 7.8% |
| 2026 1Q | 1,999억 | 336억 | 275억 | 16.8% |
Company
Address: 경기도 과천시 과천대로7길 38 -
Peers in the same sector
Recent filings
- 2026-08-14반기보고서 (2026.06)
- 2026-05-15분기보고서 (2026.03)
- 2026-04-30주요사항보고서(영업정지) Major
- 2026-03-18사업보고서 (2025.12)
- 2025-11-14분기보고서 (2025.09)
- 2025-08-14반기보고서 (2025.06)
- 2025-05-15분기보고서 (2025.03)
Source: DART (Financial Supervisory Service electronic disclosure)
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.